Evidence map›Paper›PMID 28522826›Full record

ArticleScientific reports2017

Disruption of melatonin synthesis is associated with impaired 14-3-3 and miR-451 levels in patients with autism spectrum disorders.

Cécile Pagan, Hany Goubran-Botros, Richard Delorme, Marion Benabou, Nathalie Lemière, Kerren Murray, Frédérique Amsellem, Jacques Callebert, Pauline Chaste, Stéphane Jamain and 6 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 4 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 4 syntheses or guidelines pooled it, 106 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Circadian preference and quality of life in adults with autism spectrum disorder: a Brazilian cross-sectional self-reported survey.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026
    Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 10 institutions in 2 countries.

Cécile PaganInstitut Pasteur, Human Genetics and Cognitive Functions Unit, Paris, France.
Hany Goubran-BotrosInstitut Pasteur, Human Genetics and Cognitive Functions Unit, Paris, France.
Richard DelormeInstitut Pasteur, Human Genetics and Cognitive Functions Unit, Paris, France.
Marion BenabouInstitut Pasteur, Human Genetics and Cognitive Functions Unit, Paris, France.
Nathalie LemièreInstitut Pasteur, Human Genetics and Cognitive Functions Unit, Paris, France.
Kerren MurrayInstitut Pasteur, Human Genetics and Cognitive Functions Unit, Paris, France.
Frédérique AmsellemInstitut Pasteur, Human Genetics and Cognitive Functions Unit, Paris, France.
Jacques CallebertService de Biochimie et Biologie Moléculaire, INSERM U942, Hôpital Lariboisière, APHP, 75010, Paris, France.
Pauline ChasteInstitut Pasteur, Human Genetics and Cognitive Functions Unit, Paris, France.
Stéphane JamainFondation FondaMental, 94000, Créteil, France.
Fabien FauchereauInstitut Pasteur, Human Genetics and Cognitive Functions Unit, Paris, France.
Guillaume HuguetInstitut Pasteur, Human Genetics and Cognitive Functions Unit, Paris, France.
Erik MarondeInstitute for Anatomy III, Goethe-Universität, 60590, Frankfurt/Main, Germany.
Marion LeboyerFondation FondaMental, 94000, Créteil, France.
Jean-Marie LaunayFondation FondaMental, 94000, Créteil, France. jean-marie.launay@aphp.fr.
Thomas BourgeronInstitut Pasteur, Human Genetics and Cognitive Functions Unit, Paris, France. thomasb@pasteur.fr.
Fondation FondaMental · FRGènes, synapses et cognition · FRUniversité Paris Cité · FRAssistance Publique – Hôpitaux de Paris · FRCentre National de la Recherche Scientifique · FRGoethe University Frankfurt · DEHospices Civils de Lyon · FRInstitut Pasteur · FRSorbonne Paris Cité · FRUniversité Paris-Est Créteil · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autism spectrum disorders (ASD) are characterized by a wide genetic and clinical heterogeneity. However, some biochemical impairments, including decreased melatonin (crucial for circadian regulation) and elevated platelet N-acetylserotonin (the precursor of melatonin) have been reported as very frequent features in individuals with ASD. To address the mechanisms of these dysfunctions, we investigated melatonin synthesis in post-mortem pineal glands - the main source of melatonin (9 patients and 22 controls) - and gut samples - the main source of serotonin (11 patients and 13 controls), and in blood platelets from 239 individuals with ASD, their first-degree relatives and 278 controls. Our results elucidate the enzymatic mechanism for melatonin deficit in ASD, involving a reduction of both enzyme activities contributing to melatonin synthesis (AANAT and ASMT), observed in the pineal gland as well as in gut and platelets of patients. Further investigations suggest new, post-translational (reduced levels of 14-3-3 proteins which regulate AANAT and ASMT activities) and post-transcriptional (increased levels of miR-451, targeting 14-3-3ζ) mechanisms to these impairments. This study thus gives insights into the pathophysiological pathways involved in ASD.

Indexed as

14-3-3 ProteinsAcetylserotonin O-MethyltransferaseAdolescentAdultArylalkylamine N-AcetyltransferaseAutism Spectrum DisorderBlood PlateletsCase-Control StudiesChildFemaleHumansIntestinal MucosaMaleMelatoninMicroRNAsMiddle Aged14-3-3 ProteinsAANAT protein, humanAcetylserotonin O-MethyltransferaseArylalkylamine N-AcetyltransferaseASMT protein, humanMelatoninMicroRNAsMIRN451 microRNA, humanYWHAZ protein, human

Identifiers

PMID28522826
PMCPMC5437096
OpenAlexW2614053129

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.